DA
Danielle Antalffy UBS Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Medtronic
MDT
$119B
| $92.85 | $95 |
2%
upside
| Neutral | 15 days ago |
|
2
Treace Medical Concepts
TMCI
$453M
| $7.17 | $6.50 |
9%
downside
| Neutral | 27 days ago |
|
3
RxSight
RXST
$347M
| $8.47 | $8 |
6%
downside
| Neutral | 27 days ago |
|
4
Enovis
ENOV
$1.8B
| $31.55 | $57 |
81%
upside
| Buy | 27 days ago |
|
5
Zimmer Biomet
ZBH
$20.8B
| $104.76 | $96 |
8%
downside
| Sell | 27 days ago |
|
6
Tandem Diabetes Care
TNDM
$837M
| $12.39 | $17 |
37%
upside
| Neutral | 28 days ago |
|
7
Inspire Medical Systems
INSP
$2.55B
| $86.32 | $230 |
166%
upside
| Buy | 1 month ago |
|
8
Baxter International
BAX
$12.1B
| $23.58 | $24 |
2%
upside
| Neutral | 1 month ago |
|
9
Glaukos
GKOS
$5.17B
| $90.14 | $134 |
49%
upside
| Buy | 1 month ago |
|
10
DexCom
DXCM
$31.7B
| $80.76 | $106 |
31%
upside
| Buy | 1 month ago |
|
11
Boston Scientific
BSX
$159B
| $107.29 | $135 |
26%
upside
| Buy | 1 month ago |
|
12
Intuitive Surgical
ISRG
$163B
| $454.52 | $585 |
29%
upside
| Neutral | 1 month ago |
|
13
Johnson & Johnson
JNJ
$431B
| $178.76 | $190 |
6%
upside
| Buy | 1 month ago |
|
14
AtriCure
ATRC
$1.77B
| $35.66 | $58 |
63%
upside
| Buy | 4 months ago |
|
15
InMode
INMD
$911M
| $14.41 | $16.25 |
13%
upside
| Neutral | 4 months ago |
|
16
Abbott
ABT
$231B
| $132.81 | $148 |
11%
upside
| Buy | 7 months ago |
|
17
Stryker
SYK
$151B
| $394.34 | $370 |
6%
downside
| Neutral | 10 months ago |
|
18
Edwards Lifesciences
EW
$47.5B
| $80.96 | $75 |
7%
downside
| Neutral | 1 year ago |
|
19
Butterfly Network
BFLY
$385M
| $1.53 | $2.25 |
47%
upside
| Neutral | 2 years ago |
|
|
20
RxSight
RXST
$347M
| $8.47 | $14 |
65%
upside
| Outperform | 3 years ago |
|
21
Insulet
PODD
$24.4B
| $346.47 | $280 |
19%
downside
| Outperform | 3 years ago |
|
22
Axogen
AXGN
$709M
| $15.40 | $14 |
9%
downside
| Outperform | 3 years ago |
|
|
23
Tandem Diabetes Care
TNDM
$837M
| $12.39 | $110 |
788%
upside
| Market Perform | 3 years ago |
|
|
24
Zimmer Biomet
ZBH
$20.8B
| $104.76 | $140 |
34%
upside
| Outperform | 3 years ago |
|
|
25
AtriCure
ATRC
$1.77B
| $35.66 | $75 |
110%
upside
| Outperform | 3 years ago |
|